Subscribe to newsletters
Investing in the stock market can be a rollercoaster ride, filled with ups and downs that can leave even the most seasoned investors feeling uncertain. Such fluctuations were recently witnessed in the case of Madrigal Pharmaceuticals, whose stock experienced a…
Introduction: GigaCloud, a prominent player in the tech industry, is set to release its fourth-quarter earnings report on March 15. With anticipation running high amidst a notable surge in its stock performance, investors are eager to gain insights into the…
In a stunning display of bullish momentum, Bitcoin, the leading cryptocurrency, has shattered records, surging to new heights near $73,000. This monumental milestone has captivated the attention of investors worldwide and underscores the ongoing evolution and maturation of the cryptocurrency…
February’s performance in the realm of top ETFs and mutual funds paints a picture of a bullish market, echoing sentiments of risk-taking reminiscent of historic surges in tech stocks. Lipper Refinitiv data reveals an average gain of 4.97% for U.S.…
Shares of Biogen (BIIB) soared on Friday following news of a setback in the approval process for Eli Lilly’s (LLY) competing Alzheimer’s treatment, donanemab. The Food and Drug Administration (FDA) had been expected to make a decision on donanemab this…
Dow Jones futures held steady early Friday, mirroring the stability seen in S&P 500 futures and Nasdaq futures as investors eagerly awaited the release of the February jobs report. Thursday saw robust gains in the stock market rally, with both…
CrowdStrike Holdings (CRWD) witnessed a surge in its shares on Wednesday following its fourth-quarter earnings report, which surpassed expectations and showcased robust growth metrics. The company’s fiscal 2025 guidance also exceeded projections. After reporting earnings post-market close on Tuesday, CrowdStrike…
Dow Jones fates rose early Wednesday, alongside S&P 500 prospects and Nasdaq prospects, while Bitcoin bounce back. CrowdStrike (CRWD) took off for the time being, featuring key profit reports with Took care of boss Jerome Powell approaching Wednesday morning.The financial…
BridgeBio Pharma, a prominent player in the biotech industry, has secured a significant deal worth $310 million with Bayer for the commercial rights to its leading asset, acoramidis, in Europe. This experimental treatment targets transthyretin amyloid cardiomyopathy, a hereditary condition…
Dow Jones fates will open Sunday night, alongside S&P 500 prospects and Nasdaq fates.The financial exchange rally kept on progressing, with the Nasdaq composite hitting a record high, joining the S&P 500. Taiwan Semiconductor Assembling (TSM), Solid Power Frameworks (MPWR),…